Thyroid hormone receptor subtype-&bgr;β-selective agonists as potential treatments for metabolic syndrome

Author： Grover Gary J Kelly Jane Malm Johan

ISSN： 1746-0875

Source： Future Lipidology, Vol.2, Iss.6, 2007-12, pp. : 641-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promoter methylation and THRβ expression

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 485-489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver‐selective thyroid hormone receptor agonist eprotirome

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 3, 2015-03 ,pp. : 331-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel 1297-1304delGCCTGCCA Mutation in the Exon 10 of the Thyroid Hormone Receptor Gene Causes Resistance to Thyroid Hormone

By Rivolta Carina M.

Molecular Diagnosis, Vol. 8, Iss. 3, 2004-01 ,pp. : 163-169

Adis International

Access to resources Recommend Favorite

Biochemical characterization of four novel mutations in the thyroid hormone receptor β gene in patients with resistance to thyroid hormone

By Asadi B. A. Torjesen P. A. Haug E. Berg J. P.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 7, 2008-01 ,pp. : 563-567

Informa Healthcare

Access to resources Recommend Favorite

Functional foods as potential therapeutic options for metabolic syndrome

OBESITY REVIEWS, Vol. 16, Iss. 11, 2015-11 ,pp. : 914-941

John Wiley & Sons Inc

Access to resources Recommend Favorite